Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Slow drugs: slow progress? Use of slow acting antirheumatic drugs (SAARDs) in rheumatoid arthritis.

Literature DB >> 1575601

Slow drugs: slow progress? Use of slow acting antirheumatic drugs (SAARDs) in rheumatoid arthritis.

H A Capell¹, M Brzeski.

Abstract

Entities: Disease

Mesh：

Substances：
Drug Combinations

Year: 1992 PMID： 1575601 PMCID： PMC1004681 DOI： 10.1136/ard.51.3.424

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

× No keyword cloud information.

58 in total

1. Remodeling the pyramid--a concept whose time has come.

Authors: K R Wilske; L A Healey
Journal: J Rheumatol Date: 1989-05 Impact factor: 4.666

2. The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozolol.

Authors: J J Belch; R Madhok; B McArdle; K McLaughlin; C Kluft; C D Forbes; R D Sturrock
Journal: Q J Med Date: 1986-01

3. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis.

Authors: D M van der Heijde; P L van Riel; I H Nuver-Zwart; F W Gribnau; L B vad de Putte
Journal: Lancet Date: 1989-05-13 Impact factor: 79.321

4. Study of sulphamethoxazole in rheumatoid arthritis.

Authors: G Ash; R Baker; C Rajapakse; D R Swinson
Journal: Br J Rheumatol Date: 1986-08

5. Comparison of phenytoin and gold as second line drugs in rheumatoid arthritis.

Authors: I M Richards; S M Fraser; J A Hunter; H A Capell
Journal: Ann Rheum Dis Date: 1987-09 Impact factor: 19.103

6. The use of a pharmacological indicator to investigate compliance in patients with a poor response to antirheumatic therapy.

Authors: T Pullar; S Peaker; M F Martin; H A Bird; M P Feely
Journal: Br J Rheumatol Date: 1988-10

7. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis.

Authors: J M Kremer; J K Lee
Journal: Arthritis Rheum Date: 1986-07

8. Timegadine: more than a non-steroidal for the treatment of rheumatoid arthritis. A controlled, double-blind study.

Authors: C Egsmose; B Lund; R B Andersen
Journal: Scand J Rheumatol Date: 1988 Impact factor: 3.641

9. A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis.

Authors: H J Williams; J R Ward; S L Dahl; D O Clegg; R F Willkens; T Oglesby; M H Weisman; S Schlegel; R M Michaels; M E Luggen
Journal: Arthritis Rheum Date: 1988-06

10. Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled study.

Authors: D L Scott; P T Dawes; E Tunn; P D Fowler; M F Shadforth; J Fisher; S Clarke; M Collins; P Jones; A J Popert
Journal: Br J Rheumatol Date: 1989-04

8 in total

Review 5. Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.

Authors: C P Rains; S Noble; D Faulds
Journal: Drugs Date: 1995-07 Impact factor: 9.546

6. A simple in vivo model of collagen degradation using collagen-gelled cotton buds: the effects of collagenase inhibitors and other agents.

Authors: E H Karran; K Dodgson; S J Harris; R E Markwell; G P Harper
Journal: Inflamm Res Date: 1995-01 Impact factor: 4.575

7. A history of the term "DMARD".

Authors: Jonas Kure Buer
Journal: Inflammopharmacology Date: 2015-05-23 Impact factor: 4.473

Review 8. To stop the erosion of hope: the DMARD category and the place of semantics in modern rheumatology.

Authors: Jonas Kure Buer
Journal: Inflammopharmacology Date: 2017-02-13 Impact factor: 4.473